Evidence-based Screening Strategies for Celiac Disease
NCT03136731 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 3517
Last updated 2023-01-19
Summary
Main aim: To find evidence-based screening strategies for celiac disease in high risk groups and to find new biomarkers or biomarker combinations for celiac disease diagnostics and follow-up.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Celiac disease antibody screening
Observational parameters
Sponsors & Collaborators
-
Katri Kaukinen
lead OTHER
Eligibility
- Min Age
- 6 Months
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-11-29
- Primary Completion
- 2023-12-31
- Completion
- 2032-12-31
Countries
- Finland
Study Locations
More Related Trials
-
Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis
NCT05810441 ·Status: COMPLETED
-
Improved Diagnostics of Celiac Disease in Children
NCT02072590 ·Status: COMPLETED
-
Background of Different Phenotypes of Coeliac Disease
NCT05597904 ·Status: RECRUITING
-
Screen-detected Coeliac Disease, a Population Based Study
NCT01695681 ·Status: COMPLETED ·Phase: NA
-
Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease
NCT06324539 ·Status: RECRUITING
-
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
NCT03409796 ·Status: COMPLETED ·Phase: NA
-
Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease
NCT02805816 ·Status: COMPLETED
-
Mass Screening for the Early Detection of Patients With Celiac Disease.
NCT05186038 ·Status: COMPLETED
-
Gluten Technology and Education for Celiac Health
NCT06059716 ·Status: RECRUITING ·Phase: NA
-
Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up Study
NCT04958356 ·Status: ACTIVE_NOT_RECRUITING
-
Quantification of Gluten Peptides in Feces
NCT02711397 ·Status: COMPLETED
-
No-biopsy Approach in Celiac Disease: Cut-off Points for IgA Anti-tissue Transglutaminase Assays
NCT05983978 ·Status: RECRUITING
-
Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease?
NCT00175760 ·Status: COMPLETED
-
Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies
NCT05530070 ·Status: RECRUITING ·Phase: NA
-
Gluten-free Oats and Gastrointestinal Health in Coeliac Disease, Part 1
NCT02764931 ·Status: COMPLETED ·Phase: NA
-
Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting
NCT02675283 ·Status: COMPLETED ·Phase: NA
-
Serological Identification of Celiac Disease in Kids
NCT03966625 ·Status: COMPLETED
-
A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease
NCT03521180 ·Status: COMPLETED
-
Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.
NCT02242123 ·Status: COMPLETED
-
Impact of Gluten Contamination in Celiac Patients Clinically Responsive and Unresponsive to the Gluten-free Diet
NCT05066191 ·Status: UNKNOWN
-
Risk Factors for the Development of Celiac Disease in Genetically Predisposed Children
NCT04034303 ·Status: UNKNOWN
-
Detection of Immunotoxic Gluten Peptides in Feces
NCT01478867 ·Status: COMPLETED
-
Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease
NCT00250146 ·Status: TERMINATED ·Phase: NA
-
Gluten-free Diet in Gluten-genetically Predisposed Subjects
NCT00677495 ·Status: COMPLETED ·Phase: NA
-
Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease
NCT03462979 ·Status: SUSPENDED ·Phase: NA